Shares of Stericycle Inc (NASDAQ:SRCL) have been given an average recommendation of “Hold” by the fifteen research firms that are covering the firm. Two research analysts have rated the stock with a sell recommendation, nine have assigned a hold recommendation and four have issued a buy recommendation on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $87.89.
SRCL has been the topic of several recent analyst reports. Jefferies Group LLC set a $108.00 price target on shares of Stericycle and gave the company a “buy” rating in a report on Thursday, March 16th. Macquarie set a $100.00 price target on shares of Stericycle and gave the company a “buy” rating in a report on Monday, February 6th. Stifel Nicolaus set a $90.00 price target on shares of Stericycle and gave the company a “buy” rating in a report on Monday, February 6th. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a report on Friday, January 13th. Finally, Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Stericycle in a report on Monday, February 20th.
TRADEMARK VIOLATION NOTICE: “Stericycle Inc (SRCL) Given Average Rating of “Hold” by Brokerages” was reported by Web Breaking News and is the sole property of of Web Breaking News. If you are accessing this piece on another publication, it was illegally copied and reposted in violation of US & international trademark and copyright legislation. The legal version of this piece can be read at http://www.webbreakingnews.com/2017/03/25/stericycle-inc-srcl-given-average-rating-of-hold-by-brokerages.html.
Shares of Stericycle (NASDAQ:SRCL) opened at 82.05 on Monday. The stock has a 50 day moving average of $81.07 and a 200 day moving average of $78.17. Stericycle has a one year low of $71.52 and a one year high of $128.94. The stock has a market cap of $6.99 billion, a P/E ratio of 39.45 and a beta of 0.08.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Wednesday, February 15th. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.93 by $0.07. The firm had revenue of $906.40 million for the quarter, compared to analysts’ expectations of $902.62 million. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. During the same period in the prior year, the company posted $1.11 earnings per share. Equities analysts expect that Stericycle will post $4.63 EPS for the current fiscal year.
In other Stericycle news, Director Mike S. Zafirovski bought 2,920 shares of the company’s stock in a transaction on Thursday, February 23rd. The shares were bought at an average cost of $85.67 per share, with a total value of $250,156.40. Following the completion of the acquisition, the director now owns 2,920 shares of the company’s stock, valued at $250,156.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert S. Murley bought 1,000 shares of the company’s stock in a transaction on Wednesday, February 1st. The shares were acquired at an average cost of $76.22 per share, for a total transaction of $76,220.00. The disclosure for this purchase can be found here. 3.30% of the stock is currently owned by corporate insiders.
Hedge funds have recently modified their holdings of the company. Capstone Asset Management Co. boosted its stake in shares of Stericycle by 0.3% in the third quarter. Capstone Asset Management Co. now owns 7,633 shares of the company’s stock worth $612,000 after buying an additional 20 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in shares of Stericycle by 0.4% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 4,877 shares of the company’s stock worth $376,000 after buying an additional 20 shares during the period. Capital Analysts LLC boosted its stake in shares of Stericycle by 6.2% in the fourth quarter. Capital Analysts LLC now owns 1,294 shares of the company’s stock worth $100,000 after buying an additional 76 shares during the period. BB&T Securities LLC boosted its stake in shares of Stericycle by 0.7% in the third quarter. BB&T Securities LLC now owns 10,957 shares of the company’s stock worth $878,000 after buying an additional 81 shares during the period. Finally, Bell State Bank & Trust boosted its stake in shares of Stericycle by 3.3% in the third quarter. Bell State Bank & Trust now owns 3,000 shares of the company’s stock worth $240,000 after buying an additional 95 shares during the period. 94.49% of the stock is currently owned by institutional investors.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc and related companies with MarketBeat.com's FREE daily email newsletter.